Table 3.
Prognostic factors for mortality rate in patients undergoing an LEA for diabetic foot (univariate and multivariate analyses)
Univariate | Multivariate | |||
---|---|---|---|---|
Prognostic factor | p-value | HR (95% CI) | p-value | HR (95% CI) |
Age | 0.000 | 1.033 (1.014–1.052) | 0.003 | 1.031 (1.010–1.053) |
Gender | 0.218 | 0.749 (0.473–1.186) | 0.784 | 0.909 (0.458–1.803) |
Body weight | 0.378 | 1.009 (0.988–1.030) | 0.030 | 1.029 (1.003–1.055) |
Height | 0.785 | 0.698 (0.052–9.302) | 0.265 | 0.100 (0.002–5.760) |
Sarcopenia | 0.016 | 2.252 (1.161–4.369) | 0.047 | 1.747 (1.008–3.027) |
Creatinine | 0.884 | 1.015(0.829–1.242) | 0.388 | 1.091(0.895–1.330) |
HbA1C | 0.195 | 0.829(0.624–1.101) | 0.285 | 0.857(0.646–1.137) |
Fasting glucose | 0.759 | 1.001(0.993–1.010) | 0.701 | 1.002(0.993–1.011) |
Hypertension | 0.684 | 1.571(1.145–1.842) | 0.517 | 0.842(0.065–1.145) |
Cardiac disease | 0.041 | 1.015(0.978–1.145) | 0.034 | 1.175(1.012–1.248) |
Pulmonary disease | 0.248 | 2.154(1.784–2.426) | 0.148 | 1.715(1.458–2.012) |
Cerebrovascular disease | 0.374 | 1.515(1.215–1.842) | 0.314 | 1.126(0.865–1.458) |
Renal disease | 0.084 | 1.254(0.845–1.658) | 0.145 | 1.548(1.256–1.842) |